Status:
COMPLETED
Dermal Photo Allergic Skin Reaction
Lead Sponsor:
Vyne Therapeutics Inc.
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
A 6-Week, Randomized Study to Evaluate the Potential of FMX-101, 4% And Vehicle to Induce a Photo Allergic Skin Reaction in Healthy Volunteers, Using a Controlled Photo Patch Test Design
Eligibility Criteria
Inclusion
- Healthy male or female who were 18 years of age or older
- Had uniformly-colored skin on the lower thoracic area of the back which allowed discernment of erythema, and were Fitzpatrick Skin Types I, II or III
Exclusion
- Had any visible skin disease at the application site which, in the opinion of the investigative personnel, would have interfered with the evaluation of the test site reaction
- Had damaged skin in or around the test sites, including sunburn, excessively deep tans, uneven skin tones, tattoos, scars, excessive hair, numerous freckles or other disfigurations of the test site
Key Trial Info
Start Date :
September 21 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2016
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04070755
Start Date
September 21 2016
End Date
December 18 2016
Last Update
August 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.